PubMed:32586394 / 3247-3413 JSONTXT

{"target":"https://pubannotation.org/docs/sourcedb/PubMed/sourceid/32586394","sourcedb":"PubMed","sourceid":"32586394","source_url":"https://www.ncbi.nlm.nih.gov/pubmed/32586394","text":"Control Group (Low-Dose LMWH): patients in this group will be administered Enoxaparin (Inhixa®) at standard prophylactic dose (i.e., 4000 UI subcutaneously once day).","tracks":[{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T18","span":{"begin":48,"end":53},"obj":"Chemical"},{"id":"T19","span":{"begin":75,"end":85},"obj":"Chemical"}],"attributes":[{"id":"A18","pred":"chebi_id","subj":"T18","obj":"http://purl.obolibrary.org/obo/CHEBI_24433"},{"id":"A19","pred":"chebi_id","subj":"T19","obj":"http://purl.obolibrary.org/obo/CHEBI_28304"},{"subj":"T18","pred":"source","obj":"LitCovid-PD-CHEBI"},{"subj":"T19","pred":"source","obj":"LitCovid-PD-CHEBI"}]},{"project":"LitCovid-sentences","denotations":[{"id":"T30","span":{"begin":0,"end":166},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"attributes":[{"subj":"T30","pred":"source","obj":"LitCovid-sentences"}]}],"config":{"attribute types":[{"pred":"source","value type":"selection","values":[{"id":"LitCovid-PD-CHEBI","color":"#93ecd9","default":true},{"id":"LitCovid-sentences","color":"#ecbf93"}]}]}}